CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 11  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0839
LYS 10.0513
GLU 20.0491
LEU 30.0406
ARG 40.0304
CYS 50.0077
GLN 60.0140
CYS 70.0263
ILE 80.0839
LYS 90.0449
THR 100.0180
TYR 110.0095
SER 120.0166
LYS 130.0186
PRO 140.0164
PHE 150.0145
HIS 160.0152
PRO 170.0076
LYS 180.0157
PHE 190.0117
ILE 200.0059
LYS 210.0104
GLU 220.0087
LEU 230.0098
ARG 240.0119
VAL 250.0091
ILE 260.0074
GLU 270.0135
SER 280.0293
GLY 290.0521
PRO 300.0711
HIS 310.0431
CYS 320.0294
ALA 330.0436
ASN 340.0258
THR 350.0068
GLU 360.0083
ILE 370.0113
ILE 380.0125
VAL 390.0079
LYS 400.0078
LEU 410.0069
SER 420.0139
ASP 430.0151
GLY 440.0132
ARG 450.0081
GLU 460.0086
LEU 470.0089
CYS 480.0121
LEU 490.0102
ASP 500.0123
PRO 510.0090
LYS 520.0133
GLU 530.0167
ASN 540.0217
TRP 550.0173
VAL 560.0129
GLN 570.0168
ARG 580.0157
VAL 590.0090
VAL 600.0097
GLU 610.0122
LYS 620.0030
PHE 630.0051
LEU 640.0151
LYS 650.0131
ARG 660.0174
ALA 670.0256
GLU 680.0355
ASN 690.0414

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.